Microbot Medical director granted 10,000 options

Microbot Medical Inc. director Burell Scott R reported receiving a grant of stock options.

Rhea-AI Filing Summary

Microbot Medical Inc. director Burell Scott R reported receiving a grant of stock options. On April 1, 2026, he was awarded options to acquire 10,000 shares of common stock at an exercise price of $2.37 per share, expiring on April 1, 2036. Following this grant, he holds stock options covering 10,000 underlying shares directly.

Insights

Equity compensation analyst

Director received 10,000 stock options in a routine grant.

Director Burell Scott R received stock options for 10,000 shares of Microbot Medical common stock at an exercise price of $2.37 per share. The options were granted on April 1, 2026 and expire on April 1, 2036.

This is classified as a grant, award, or other acquisition, not an open-market transaction. The filing shows total derivative holdings of options on 10,000 shares after the grant, indicating this award establishes his current option position visible here.

Insider Trade Summary

Grant/Award: 10,000 shares

Grant/Award 1 txn

Insider Burell Scott R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	10,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 10,000 contracts (Direct)

Key Figures

Options granted: 10,000 options Exercise price: $2.37 per share Expiration date: April 1, 2036 +1 more

4 metrics

Options granted 10,000 options Stock Option (Right to Buy) granted April 1, 2026

Exercise price $2.37 per share Conversion or exercise price for granted options

Expiration date April 1, 2036 Options expiration for this grant

Derivative holdings after grant 10,000 underlying shares Total shares underlying options following transaction

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, Common Stock, par value $0.01 per share

3 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock, par value $0.01 per share financial

"underlying_security_title: "Common Stock, par value $0.01 per share""

FAQ

What did Microbot Medical (MBOT) director Burell Scott R report on this Form 4?

He reported receiving a grant of stock options for 10,000 shares of Microbot Medical common stock. These options give him the right to buy shares at a fixed exercise price in the future, as detailed in the filing.

What is the exercise price of the Microbot Medical (MBOT) options granted to the director?

The stock options were granted with an exercise price of $2.37 per share. This means he can purchase Microbot Medical common shares at $2.37 each if he chooses to exercise the options before they expire.

When do the stock options granted to the Microbot Medical (MBOT) director expire?

The options granted to the director expire on April 1, 2036. He can exercise the right to buy up to 10,000 shares at the fixed exercise price of $2.37 per share any time before that expiration date, subject to plan terms.

How many shares are covered by the options reported in this Microbot Medical (MBOT) Form 4?

The grant covers options on 10,000 underlying shares of Microbot Medical common stock. After this grant, the reporting person’s total derivative holdings shown in the filing are options representing those same 10,000 shares, held directly.

Was this Microbot Medical (MBOT) Form 4 an open-market stock purchase or sale?

No, it was not an open-market trade. The filing classifies the transaction as a grant, award, or other acquisition of stock options, giving the director rights to buy shares later rather than reflecting an immediate market purchase or sale.

How is the ownership of the granted Microbot Medical (MBOT) options classified?

The filing classifies the options as held with direct ownership by the reporting person. There are no additional entities or indirect ownership structures referenced here, and total derivative holdings following the transaction are the 10,000 options granted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burell Scott R

(Last) (First) (Middle)

C/O MICROBOT MEDICAL INC.

175 DERBY ST., BLD. 27

(Street)

HINGHAM MASSACHUSETTS 02043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Microbot Medical Inc. [ MBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.37	04/01/2026		A		10,000		04/01/2026	04/01/2036	Common Stock, par value $0.01 per share	10,000	$0	10,000	D

Explanation of Responses:

	/s/ Scott Burell	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)